You are here:

pramipexole (Mirapexin)


Following a full submission.

Pramipexole (Mirapexin) is accepted for use within NHS Scotland for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS). It should only be used in patients with a baseline score of 15 points or more on the International Restless Legs Scale (IRLS).

In three double blind placebo-controlled studies pramipexole was associated with a 4 to 9-point improvement on the patient-administered 40-point IRL scale in comparison with placebo based on the core clinical features of the syndrome.

Drug Details

Drug Name: pramipexole (Mirapexin)
SMC Drug ID: 247/06
Manufacturer: Boehringer Ingelheim Ltd
Indication: Moderate to severe idiopathic Restless Legs Syndrome
BNF Category:
Sub Category: 4.9 Drugs used in Parkinsonism and related disorders
Submission Type: Full submission
Status: Accepted
Date Advice Published: 8 May 2006